BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/7/2018 2:30:09 AM | Browse: 570 | Download: 992
Publication Name World Journal of Gastroenterology
Manuscript ID 41459
Country/Territory United States
Received
2018-08-08 07:34
Peer-Review Started
2018-08-08 08:17
To Make the First Decision
2018-08-27 01:57
Return for Revision
2018-08-27 06:10
Revised
2018-10-04 05:36
Second Decision
2018-10-15 08:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-10-15 18:20
Articles in Press
2018-10-15 18:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-11-06 03:52
Publish the Manuscript Online
2018-11-07 02:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients
Manuscript Source Invited Manuscript
All Author List Tarek Sawas, Fateh Bazerbachi, Samir Haffar, Won K Cho, Michael Levy, John A Martin, Bret T Petersen, Mark Topazian, Vinay Chandrasekhara and Barham K Abu Dayyeh
ORCID
Author(s) ORCID Number
Tarek Sawas http://orcid.org/0000-0002-0025-9827
Fateh Bazerbachi http://orcid.org/0000-0003-4599-2042
Samir Haffar http://orcid.org/0000-0002-4467-941X
Won K Cho http://orcid.org/0000-0003-0918-0565
Michael Levy http://orcid.org/0000-0002-0801-5392
John A Martin http://orcid.org/0000-0002-9499-9358
Bret T Petersen http://orcid.org/0000-0002-5635-6706
Mark Topazian http://orcid.org/0000-0003-1090-2844
Vinay Chandrasekhara http://orcid.org/0000-0001-6209-9905
Barham K Abu Dayyeh http://orcid.org/0000-0001-8084-7225
Funding Agency and Grant Number
Corresponding Author Barham K Abu Dayyeh, MD, Associate Professor, Attending Doctor, Director, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Ave., S.W., Rochester, MN 55905, United States. abudayyeh.barham@mayo.edu
Key Words End-stage renal disease; Nationwide Inpatient Sample; Endoscopic retrograde cholangiopancreatography
Core Tip Recognizing risk factors for endoscopic retrograde cholangiopancreatography (ERCP)-related complications is essential to reduce adverse events (AEs). There are limited data evaluating ERCP outcomes in renal disease. In a retrospective cohort study using the Nationwide Inpatient Sample 2011-2013 and including 492175 dis­charges, we compared inpatient ERCP AEs, mortality and length of stay between patients with and without renal disease. We found end-stage renal disease (ESRD) to be associated with higher post ERCP pancreatitis [8.3%, adjusted odd ratio (aOR) = 1.7, aP < 0.001], bleeding (5.1%, aOR = 1.86, aP < 0.001), mortality (7.1%, aOR = 6.6, aP < 0.001) and longer hospital stay (5.9 d, aP < 0.001). Physicians should consider special interventions in ESRD patients to decrease ERCP AEs.
Publish Date 2018-11-07 02:30
Citation Sawas T, Bazerbachi F, Haffar S, Cho WK, Levy MJ, Martin JA, Petersen BT, Topazian MD, Chandrasekhara V, Abu Dayyeh BK. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24(41): 4691-4697
URL http://www.wjgnet.com/1007-9327/full/v24/i41/4691.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i41.4691
Full Article (PDF) WJG-24-4691.pdf
STROBE Statement 41459-STROBE Statement.pdf
Manuscript File 41459-Review.docx
Answering Reviewers 41459-Answering reviewers.pdf
Audio Core Tip 41459-Audio core tip.wma
Biostatistics Review Certificate 41459-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 41459-Conflict-of-interest statement.pdf
Copyright License Agreement 41459-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 41459-Signed Informed Consent Form(s) or Document(s).docx
Institutional Review Board Approval Form or Document 41459-Institutional Review Board Approval Form or Document.docx
Supplementary Material 41459-Supplementary material.pdf
Peer-review Report 41459-Peer-review(s).pdf
Scientific Misconduct Check 41459-Scientific misconduct check.pdf
Scientific Editor Work List 41459-Scientific editor work list.pdf